Open AccessRelationship between Plasma Hypoxia Inducible Factor 1α in Type 2 Diabetes Mellitus with Malignancy and Without Malignancy
Author(s) -
Rusdiana Rusdiana,
Sry Suryani Widjaja,
S. Maya,
Dedi Ardinata
Publication year - 2020
Publication title -
open access macedonian journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.288
H-Index - 17
ISSN - 1857-9655
DOI - 10.3889/oamjms.2020.5138
Subject(s) - medicine , diabetes mellitus , malignancy , type 2 diabetes mellitus , hypoxia (environmental) , complication , risk factor , body mass index , gastroenterology , surgery , endocrinology , chemistry , organic chemistry , oxygen
BACKGROUND: Diabetes mellitus was associated with hypoxia condition and result ischemia and induced neovascularization and other forms of the cell adaptation in response to the tissue concentrations of low oxygen levels. Hypoxia-Inducible Factor 1 alpha a marker of the cell adaptation as a hypoxic cell response which was due of chronic hiperglycemia.
AIM: The aim of this study to know the relationship between Hba1c and plasma HIF-1 α level at type 2 diabetes mellitus patients.
METHODS: The cross-sectional study design using the 89 samples of diabetes mellitus patients who attended Murni Teguh Hospital in Medan of Indonesia country. The inclusion criteria of the samples were all the patients diagnosed with type 2 diabetes mellitus both the sexes. Body mass index, blood pressure, and disease history six socioeconomic status was recorded. The laboratory parameters, including fasting blood sugar and Hba1c were examined by Murni Teguh Hospital Laboratory.
RESULTS: The result of the study we found that there was no significant difference the hypoxia-inducible factor 1α level (HIF-1α) at type 2 diabetes mellitus with malignancy was higher compared at type 2 diabetes mellitus without malignancy.
CONCLUSION: The patient’s type 2 diabetes mellitus with the high HIF-1α levels have a poor prognosis compared with the lower levels because the high HIF-1α will tend to have a risk complication of malignancy or the other complication of diabetes mellitus.